Search research articles

Search research articles

Related Experiment Videos

Atheromatous embolization.

Yin Ping Liew¹, John R Bartholomew

¹Department of Cardiovascular Medicine, Section of Vascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.

Vascular Medicine (London, England)

|February 1, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring uric acid as a biomarker in lipedema and lymphedema: A metabolomics study with prospective validation.

Obesity medicine·2026

Same author

Lymphedema vs lipedema: Similar but different.

Cleveland Clinic journal of medicine·2024

Same author

Venous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample.

Vascular medicine (London, England)·2024

Same author

Images in Vascular Medicine: Mondor's disease due to high-output arteriovenous fistula.

Vascular medicine (London, England)·2024

Same author

Images in Vascular Medicine: Nonuremic calciphylaxis secondary to occult malignancy.

Vascular medicine (London, England)·2023

Same author

Remembering Jess R Young, MD, MSVM (1928-2021): SVM Founding Member and First President.

Vascular medicine (London, England)·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Atheromatous embolization, a complication of advanced atherosclerosis, often goes unrecognized but can cause severe organ damage. Early diagnosis and aggressive management are crucial for better patient outcomes.

Area of Science:

Cardiovascular Medicine
Vascular Biology
Nephrology

Background:

Atheromatous embolization is a multisystem disease linked to advanced atherosclerosis.
It frequently complicates procedures like angiography, endovascular interventions, and cardiovascular surgery.
This condition can present subtly or with severe consequences, including myocardial infarction, stroke, and acute renal failure.

Purpose of the Study:

To highlight the under-recognized nature of atheromatous embolization.
To emphasize the importance of high clinical suspicion for timely diagnosis.
To discuss management strategies for improving clinical outcomes and preventing end-organ damage.

Main Methods:

Clinical review of atheromatous embolization.

Related Experiment Videos

Analysis of presentation, diagnosis, and management strategies.

Discussion of risk factors and expected increase in prevalence.

Main Results:

Atheromatous embolization is often underdiagnosed due to its subtle presentation and mimicry of other diseases.
High clinical suspicion is essential for diagnosis.
Significant morbidity and mortality are associated with this condition.

Conclusions:

Early recognition and aggressive management of atheromatous embolization are vital to prevent end-organ damage.
Management includes risk factor modification, avoiding predisposing factors, supportive care, and source removal.
The prevalence of atheromatous embolization is projected to rise with aging populations and increasing rates of diabetes and obesity.